Related references
Note: Only part of the references are listed.Expression of FOXP3, CD68, and CD20 at Diagnosis in the Microenvironment of Classical Hodgkin Lymphoma Is Predictive of Outcome
Paul Greaves et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma
D. Azambuja et al.
ANNALS OF ONCOLOGY (2012)
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
P. Allavena et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
Jonathan A. Harris et al.
DIAGNOSTIC PATHOLOGY (2012)
CD68 and CD163 as prognostic factors for Korean patients with Hodgkin lymphoma
Dok Hyun Yoon et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma
Beatriz Sanchez-Espiridion et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era
Alden A. Moccia et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Systematic validation of specific phenotypic markers for in vitro polarized human macrophages
C. A. Ambarus et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Stage IV and age over 45 years are the only prognostic factors of the International Prognostic Score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series
Pablo Guisado-Vasco et al.
LEUKEMIA & LYMPHOMA (2012)
Transcriptomic analyses of murine resolution-phase macrophages
Melanie J. Stables et al.
BLOOD (2011)
The Viral Load of Epstein-Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma
Stefan Hohaus et al.
CLINICAL CANCER RESEARCH (2011)
Cancer-promoting tumor-associated macrophages: New vistas and open questions
Alberto Mantovani et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma
Peter Kamper et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Macrophages predict treatment outcome in Hodgkin's lymphoma
Christian Steidl et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment
Christian Steidl et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Identification and manipulation of tumor associated macrophages in human cancers
Moniek Heusinkveld et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
The prognostic relevance of tumor associated macrophages in advanced stage classical Hodgkin lymphoma
Ljubomir R. Jakovic et al.
LEUKEMIA & LYMPHOMA (2011)
Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma
Mona A. A. Zaki et al.
VIRCHOWS ARCHIV (2011)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Toby Lawrence et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
Hanne Van Gorp et al.
MOLECULAR IMMUNOLOGY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma
Alexandar Tzankov et al.
PATHOBIOLOGY (2010)
Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome
Bruno Chetaille et al.
BLOOD (2009)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry
E Kunisch et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
CD163-A specific marker of macrophages in paraffin-embedded tissue samples
SK Lau et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Share Paper
